Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop

Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop

Source: 
Motley Fool
snippet: 

Pfizer reported double-digit sales growth in 2022 to over $100 billion.
COVID sales are bound to drop, but the company has more vaccines to come on the horizon.